Ishihara Sangyo Kaisha (4028) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
7 Aug, 2026Executive summary
Achieved significant year-over-year growth in revenue and profits for the second quarter of FY2025, driven by strong overseas agrochemical sales, favorable currency movements, and cost improvements.
Net sales for the six months ended September 30, 2025, increased by 2.6% year-over-year to ¥76,459 million, with operating profit up 177.8% to ¥7,371 million and profit attributable to owners of parent up 676.9% to ¥5,649 million.
Comprehensive income for the period was ¥5,832 million, up 101.5% year-over-year.
Upward revision to full-year guidance, reflecting robust demand in key segments and a weaker yen.
Financial highlights
Q2 FY2025 revenue: ¥76.4 billion, up ¥1.9 billion year-over-year; gross profit increased to ¥21,655 million.
Operating income: ¥7.3 billion, up ¥4.7 billion year-over-year; ordinary income: ¥8.5 billion, up ¥6.0 billion year-over-year.
Ordinary profit rose 241.9% year-over-year to ¥8,501 million.
Basic earnings per share for the period was ¥147.66, up from ¥19.03 in the prior year.
Cash and cash equivalents at period-end were ¥38,964 million, up from ¥26,268 million a year earlier.
Outlook and guidance
Full-year revenue forecast raised to ¥152.0 billion, operating income to ¥16.0 billion, and net income to ¥12.2 billion, all above initial May guidance.
Basic earnings per share for the full year is forecast at ¥318.90.
Dividend forecast increased to ¥100 per share (interim ¥30, year-end ¥70).
Upward revision driven by strong overseas agrochemical sales and continued yen weakness.
Latest events from Ishihara Sangyo Kaisha
- Net sales rose 10.4% but net income fell 80.6% due to forex losses and higher costs.4028
Q2 20257 Aug 2026 - FY2025 is forecasted for higher profit and a ¥100 dividend as inorganic chemicals recover.4028
Q4 20257 Aug 2026 - Q1 FY2027 saw steep profit declines and a major impairment loss in Inorganic Chemicals.4028
Q1 20277 Aug 2026 - Profits surged in FY2025, but FY2026/FY2027 is forecast to decline amid higher R&D and normalized demand.4028
Q4 20265 Jun 2026 - Strong profit growth and positive outlook, driven by Organic Chemicals segment.4028
Q3 202613 Feb 2026 - Q1 FY2025 profit dropped over 40% year-over-year despite stable sales; outlook revised down.4028
Q1 202520 Nov 2025 - Sales and operating income rose, but net income fell; dividend forecast increased.4028
Q3 202520 Nov 2025 - Operating profit surged 191% year-over-year, with strong sales and raised full-year guidance.4028
Q1 202620 Nov 2025